首页> 外文OA文献 >Co-delivery of Doxorubicin and PSC 833 (Valspodar) by Stealth Nanoliposomes for Efficient Overcoming of Multidrug Resistance

【2h】

Co-delivery of Doxorubicin and PSC 833 (Valspodar) by Stealth Nanoliposomes for Efficient Overcoming of Multidrug Resistance

机译：通过隐形纳米吡咯烷瘤和PSC 833（Valspodar）的共同递送，以有效克服多药耐药性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Elmira Bajelan; Azadeh Haeri; Amir Masoud Vali; Seyed Nasser Ostad; Simin Dadashzadeh;
展开▼
作者单位

展开▼
年度 2012
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Co-delivery of Doxorubicin and PSC 833 (Valspodar) by Stealth Nanoliposomes for Efficient Overcoming of Multidrug Resistance [J] . Elmira Bajelan, Azadeh Haeri, Amir Masoud Vali, Journal of Pharmacy and Pharmaceutical Sciences . 2012,第4期

机译：隐形纳米脂质体与阿霉素和PSC 833（Valspodar）共同给药可有效克服多重耐药性
2. A phase I trial of liposomal doxorubicin, paclitaxel and valspodar (PSC-833), an inhibitor of multidrug resistance. [J] . Advani R, Lum BL, Fisher GA, Annals of oncology: official journal of the European Society for Medical Oncology . 2005,第12期

机译：脂质体阿霉素，紫杉醇和valspodar（PSC-833）（一种多药耐药性抑制剂）的I期试验。
3. Dynamic assessment of mitoxantrone resistance and modulation of multidrug resistance by valspodar (PSC833) in multidrug resistance human cancer cells. [J] . Shen F, Bailey BJ, Chu S The Journal of Pharmacology and Experimental Therapeutics: Official Publication of the American Society for Pharmacology and Experimental Therapeutics . 2009,第2期

机译：valspodar（PSC833）在具有多重耐药性的人类癌细胞中对米托蒽醌耐药性的动态评估和对多重耐药性的调节。
4. Co-delivery of ETS1 siRNA and doxorubicin using supramolecular nanoparticles to overcome adriamycin resistance via downregulation of MDR1 transcription [C] . Min Wu, Yang Li, Xingang Liu, World biomaterials congress . 2016

机译：使用超分子纳米粒子共同递送ETS1 siRNA和阿霉素以通过下调MDR1转录克服对阿霉素的耐药性
5. The pharmacokinetic analysis of a therapeutic drug interaction between a type-1 multidrug resistance modulator, valspodar (PSC 833), and an anticancer agent, doxorubicin, in patients. [D] . Naik, George Oliver Archibald. 2005

机译：对患者的1型多药抗性调节剂valspodar（PSC 833）和抗癌药阿霉素之间的治疗药物相互作用的药代动力学分析。
6. Dynamic Assessment of Mitoxantrone Resistance and Modulation of Multidrug Resistance by Valspodar (PSC833) in Multidrug Resistance Human Cancer Cells [O] . Fei Shen, Barbara J. Bailey, Shaoyou Chu, -1

机译：动态评估米托蒽醌抗药性和多药调制 Valspodar（PSC833）对多药耐药人类癌症的耐药性细胞
7. Dynamic Assessment of Mitoxantrone Resistance and Modulation of Multidrug Resistance by Valspodar (PSC833) in Multidrug Resistance Human Cancer Cells [O] . Shen, Fei, Bailey, Barbara J., Chu, Shaoyou, 2009

机译：动态评估米托蒽醌抗药性和多药调制 Valspodar（PSC833）对多药耐药人类癌症的耐药性细胞

Co-delivery of Doxorubicin and PSC 833 (Valspodar) by Stealth Nanoliposomes for Efficient Overcoming of Multidrug Resistance

著录项

引文网络

相似文献

相关主题

期刊订阅